News

Ab Studio designed antibodies are at clinical stages! GB261, an Fc-Function Enabled and CD3 Affinity De-Tuned CD20/CD3 Bispecific Antibody designed by Ab Studio shows promising new results published in ASH's annual meeting.   Click here for more information.

|

Using our proven technology of computer-design and on-bench validation, SEND US YOUR PROTEIN SEQUENCE and we will provide a drug candidate OFFERING IMPROVED BALANCE OF SAFETY, EFFICACY, AND MANUFACTURABILITY.  

Resources

News and Media

Check out Dr. Yue Liu's talk on the development of multi-specific antibodies via computer aided design.

Watch Now

New research partnership with China Resources Biopharmaceutical.

Read More

IntoCell and Ab Studio to Start Research Collaboration

Read More

Improve the success rate of innovation with our antibody humanization and optimization service!

With cutting-edge AI/CAAD technology, we optimize antibodies for high humanness, low immunogenicity, enhanced affinity and improved manufacturability/developability. This translates to an increased chance of successful clinical outcomes achieved in the fraction of the time.

Empower your therapeutic endeavors and shape the future of medicine. Connect with us now to embark on a journey of innovation and impact!

Ab Studio Inc.
Watch our video
Team
Speak to a scientist
Paper
Read our paper

510-397-6439

3541 Investment Blvd. Suite 3,
Hayward, CA 94545 USA

Contact Us

abstudio.info@antibodystudio.com